Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765500
Status:
RECRUITING
Last Update Posted:
2024-02-14
First Post:
2023-03-01
Brief Title:
RecoverPC Relugolix vs GnRH Agonist in Quality of Life
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-01
First Submit QC Date:
March 1 2023
Study First Post Date:
2023-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-13
Last Update Post Date:
2024-02-14
Last Update Post Date Type:
ACTUAL